We are dedicated to serving patients' needs and improving public health in China. Our mission is to help Chinese patients gain earlier access to more affordable, innovative medicines through partnerships, best-in-class research and development, and the disruptive application of digital and data insight.
Patients are our most important stakeholders and motivate us to deliver truly innovative medicines in China. Patients will always be first in every decision we make.
Building trust with society, healthcare providers, regulators, public health advocates, our partners, and our employees is central to our core strategy and is enabled through both public and private partnerships. We are committed to working with providers and governments to address China's public health issues.
We aim to be measured by the impact we deliver for our patients and society. We will not invest in undifferentiated products simply because they are easier or cheaper to acquire. We will not put profit ahead of patient safety and benefit. We will not leave patients behind, and we commit to making our medicines more affordable and accessible.
It is critical for the patients who are taking our medicines, and for the physicians who are prescribing them, to have every assurance that they were produced in accordance with the highest quality standards. We will invest in manufacturing, tracking, and authenticating our supplies and providing support for the proper use of our medicines.